Home › Merck: Respiratory Medicine Running Out Of Breath
 

Keywords :   


Merck: Respiratory Medicine Running Out Of Breath

2013-06-26 16:09:16| Biotech - Topix.net

Merck's leading respiratory therapeutic Singulair , a once-a-day oral medicine for the chronic treatment of asthma and for the relief of symptoms of allergic rhinitis which generated more than $44 billion of revenue since its launch in February 1998, lost market exclusivity in the U.S. in August 2012.

Tags: running medicine breath respiratory

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Atlantic Tropical Weather Outlook
30.06Eastern North Pacific Tropical Weather Outlook
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 6A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Wind Speed Probabilities Number 6
30.06Hurricane Beryl Public Advisory Number 6
More »